Geographic · D&A
Americas — D&A
Zimmer Biomet Holdings Americas — D&A increased by 9.8% to $44.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.3%, from $40.70M to $44.90M. Over 4 years (FY 2021 to FY 2025), Americas — D&A shows an upward trend with a 3.4% CAGR.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026May 1, 2026
Rolls up toD&A
How to read this metric
Higher values often indicate significant capital investment in regional infrastructure, while stable values suggest consistent asset utilization.
Detailed definition
This represents the non-cash allocation of the cost of tangible and intangible assets over their useful lives within the...
Peer comparison
Commonly reported as part of segment-level EBITDA calculations across the medical device and manufacturing industries.
Metric ID:
zbh_segment_americas_depreciation_and_amortizationHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $35.78M | $35.78M | $35.78M | $32.58M | $32.58M | $32.58M | $32.58M | $33.63M | $33.63M | $33.63M | $33.63M | $36.50M | $37.10M | $38.30M | $38.50M | $40.70M | $39.80M | $42.00M | $40.90M | $44.90M |
| QoQ Change | — | +0.0% | +0.0% | -8.9% | +0.0% | +0.0% | +0.0% | +3.2% | +0.0% | +0.0% | +0.0% | +8.6% | +1.6% | +3.2% | +0.5% | +5.7% | -2.2% | +5.5% | -2.6% | +9.8% |
| YoY Change | — | — | — | — | -8.9% | -8.9% | -8.9% | +3.2% | +3.2% | +3.2% | +3.2% | +8.6% | +10.3% | +13.9% | +14.5% | +11.5% | +7.3% | +9.7% | +6.2% | +10.3% |
Range$32.58M – $44.90M
CAGR+4.9%
Avg YoY Growth+4.9%
Median YoY Growth+6.8%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Zimmer Biomet Holdings's americas — d&a?
- Zimmer Biomet Holdings (ZBH) reported americas — d&a of $44.90M in Q1 2026.
- How has Zimmer Biomet Holdings's americas — d&a changed year-over-year?
- Zimmer Biomet Holdings's americas — d&a increased by 10.3% year-over-year, from $40.70M to $44.90M.
- What is the long-term trend for Zimmer Biomet Holdings's americas — d&a?
- Over 4 years (2021 to 2025), Zimmer Biomet Holdings's americas — d&a has grown at a 3.4% compound annual growth rate (CAGR), from $143.10M to $163.40M.
- What does americas — d&a mean?
- The non-cash expense representing the aging of assets used in the Americas segment.